Loading...
Loading...
JP Morgan maintains its Neutral rating on Emerson Electric
EMR following an initial take on the company's F1Q.
JP Morgan notes, "The quarter was a little weaker than even lowered expectations, and we struggle to understand how the company hits guidance, which “surprisingly” frames consensus. In short we have several issues here. First, Thailand is less of an impact than expected, showing the deterioration here is fundamental in nature. Whether this is “structural” or not is an aspect of the argument (bolstered by data center being down), but the facts are that to support standing guidance they needed an “adjusted” number of ~$0.76 – adjusting the $0.16 for Thailand/medicare only gets us to $0.66, supportive of ~$3."
EMR closed at $53.37 a share on Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in